Physician profile
Francis Messick
NPI 1285646943
$788.66
in general payments reported to CMS, 2019-2025
17 companies · $107 in 2025
The $107 reported for 2025 was more than what a typical Adolescent Medicine (Pediatrics) provider received nationally (typical 2025 total: $99.31).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $157 · 2020: $109 · 2021: $99.34 · 2022: $103 · 2023: $164 · 2024: $50.18 · 2025: $107.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $321.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $321.23 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Supernus Pharmaceuticals, INC. | $171.86 | 2021-2025 | Qelbree, Qelbree |
| Tris Pharma INC | $132.96 | 2019-2022 | |
| Corium, LLC | $105.82 | 2022-2024 | Azstarys |
| Ironshore Pharmaceuticals INC. | $89.17 | 2019-2023 | Jornay Pm |
| Sanofi Pasteur INC. | $48.97 | 2024-2025 | |
| Sobi, INC | $31.41 | 2020-2023 | |
| Glaxosmithkline, LLC. | $31.05 | 2019-2021 | |
| Takeda Pharmaceuticals U.S.A., INC. | $25.66 | 2019-2020 | |
| Abbott Laboratories | $21.10 | 2021 | |
| Biomerieux INC | $21.00 | 2025 | |
| Pfizer INC. | $18.34 | 2023 | |
| Sanofi-Aventis U.S. LLC | $18.02 | 2025 | |
| Abbvie INC. | $16.45 | 2025 | |
| Adlon Therapeutics L.P. | $14.71 | 2020 | |
| Neos Therapeutics, LP | $14.38 | 2019 |
Show all 17 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| 180 Medical, INC. | $14.13 | 2020 | |
| Cranial Technologies, INC | $13.63 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Francis Messick listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.